PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
03-May-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
03-May-2022 United States Ophthalmic Compounding Pharmacies Industry Report to 2028 - Players Profiled Include Nora Apothecary, Lifecare Pharmacy, Avella Specialty Pharmacy and Triangle Compounding Pharmacy - ResearchAndMarkets.com Businesswire
03-May-2022 ADC Therapeutics to Host First Quarter 2022 Financial Results Conference Call on May 9, 2022 Businesswire
03-May-2022 Insights on the Asthma and COPD Drugs Global Market to 2030 - Key Players Include Novartis, Organon and Sanofi - ResearchAndMarkets.com Businesswire
03-May-2022 Global Systemic Scleroderma Treatment Market to 2028 - by Drug Class, Disease Type, Route of Administration, Distribution Channel, and Region - ResearchAndMarkets.com Businesswire
03-May-2022 Aura Biosciences to Present at the 2022 Bank of America Healthcare Conference Businesswire
03-May-2022 Teva Reports First Quarter 2022 Financial Results Businesswire
03-May-2022 CI Global Asset Management Launches Blockchain and Metaverse ETFs Businesswire
03-May-2022 908 Devices Partners with Key Biomanufacturing Innovation Center Businesswire
03-May-2022 Waters Corporation (NYSE: WAT) Reports First Quarter 2022 Financial Results Businesswire
03-May-2022 Pfizer Reports First-Quarter 2022 Results Businesswire
03-May-2022 Japan In-Vitro Diagnostics (IVD) Market Research Report 2022 - ResearchAndMarkets.com Businesswire
03-May-2022 International Pregistry Study Examines Treatments Used for COVID-19 During Pregnancy Businesswire
03-May-2022 Alentis Therapeutics Appoints Dr. Andrea Pellacani as Chief Medical Officer Businesswire
03-May-2022 End Drug Shortages Alliance Announces Board of Directors, Mission, Vision Statements in First All-Member Meeting Businesswire
03-May-2022 Asia Breast Cancer Screening Market Research Report 2022: Size, Forecasts, Industry Trends, Share, Growth, Impact of COVID-19, Company Analysis 2021-2027 - ResearchAndMarkets.com Businesswire
03-May-2022 NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of its Topical Investigational Drug in the Treatment of Cutaneous Metastases of Breast Cancer Businesswire
03-May-2022 Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies Businesswire
03-May-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
03-May-2022 Europe’s first dual orexin receptor antagonist – QUVIVIQ (daridorexant) – granted approval to improve both nighttime symptoms and daytime functioning in adults with chronic insomnia disorder Idorsia